DAVID L. BARKER - 26 May 2021 Form 3 Insider Report for Singular Genomics Systems, Inc.

Role
Director
Signature
/s/ David L. Barker
Issuer symbol
N/A
Transactions as of
26 May 2021
Net transactions value
$0
Form type
3
Filing time
26 May 2021, 20:34:23 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMIC Common Stock 1,000,000 26 May 2021 By The Barker/Loring Trust Dated August 27, 2013 F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMIC Employee Stock Option (right to buy) 26 May 2021 Common Stock 20,000 $22.43 Direct F2
holding OMIC Employee Stock Option (right to buy) 26 May 2021 Common Stock 60,000 $0.6300 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the trustee of the The Barker/Loring Trust Dated August 27, 2013, and has voting and dispositive power with respect to these shares.
F2 Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares vest and become exercisable upon the earlier of the 2022 Stockholder Annual Meeting or May 5, 2022.
F3 Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. The option shares vest and become exercisable in 12 equal monthly installments beginning on January 18, 2020.

Remarks:

Exhibit 24 - Power of Attorney